Earnings Call Summary | Moolec Science(MLEC.US) Q3 2024 Earnings Conference
Earnings Call Summary | Moolec Science(MLEC.US) Q3 2024 Earnings Conference
The following is a summary of the Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript:
以下是Moolec Science SA (MLEC) 2024第三季度業績會記錄摘要：
Financial Performance:
金融業績：
Revenue increased year-over-year from nil to approximately $1.3 million.
Gross margin stood at 18%.
Operational cash flow was approximately $2.7 million with a decrease in cash utilization year-over-year.
Moolec's cash position strengthened by approximately $2 million due to additional funding.
營業收入同比增長，從零增至約130萬美元。
毛利率爲18%。
運營現金流約爲270萬美元，年同比現金利用減少。
由於額外融資，Moolec現金狀況增強了約200萬美元。
Business Progress:
業務進展：
Achieved USDA-APHIS regulatory approval for Piggy Sooy.
Initiated field trials for Piggy Sooy in three different U.S. locations.
GLASO is in pre-commercial stages with intended market penetration in 2025.
Two U.S. patents granted for SPC2 technology extending protection till 2041.
Piggy Sooy已獲USDA-APHIS監管批准。
在美國三個不同地點啓動了Piggy Sooy的田間試驗。
GLASO處於商業前期階段，計劃於2025年進入市場。
SPC2技術獲得兩項美國專利，保護期延長至2041年。
Opportunities:
機會：
Moolec's Piggy Sooy provides a sustainable alternative to traditional livestock farming, reducing water and CO2 emissions.
Expected commercial adoption and scaling of Piggy Sooy and GLASO in the forthcoming years.
Moolec的Piggy Sooy提供了可持續的傳統畜牧業替代方案，減少了水和二氧化碳排放。
預計在未來幾年內，Piggy Sooy和GLASO的商業採用和規模化將會實現。
Risks:
風險：
Dependence on the success and commercial acceptance of Piggy Sooy and other products still in pre-commercial or early commercial stages.
依賴於Piggy Sooy和其他仍處於商業前期或早期商業階段的產品的成功和商業接受程度。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由AI生成。文章內容的準確性無法完全保證。有關更全面的詳細信息，請參閱IR網站。本文只是爲投資者提供參考，沒有任何指導或推薦建議。